[English] 日本語
Yorodumi
- PDB-7u5o: CRYSTAL STRUCTURE OF THE BONE MORPHOGENETIC PROTEIN RECEPTOR TYPE... -

+
Open data


ID or keywords:

Loading...

-
Basic information

Entry
Database: PDB / ID: 7u5o
TitleCRYSTAL STRUCTURE OF THE BONE MORPHOGENETIC PROTEIN RECEPTOR TYPE 2 LIGAND BINDING DOMAIN IN COMPLEX WITH ACTIVIN-B
Components
  • Bone morphogenetic protein receptor type-2
  • Inhibin beta B chain
KeywordsSIGNALING PROTEIN / Cell Signaling / Receptor-ligand complex / Growth factor / Receptor interaction / Activin B / BMPRII
Function / homology
Function and homology information


negative regulation of hepatocyte growth factor production / response to gonadotropin / semi-lunar valve development / positive regulation of ovulation / negative regulation of follicle-stimulating hormone secretion / negative regulation of chondrocyte proliferation / Antagonism of Activin by Follistatin / regulation of lung blood pressure / lymphatic endothelial cell differentiation / response to insecticide ...negative regulation of hepatocyte growth factor production / response to gonadotropin / semi-lunar valve development / positive regulation of ovulation / negative regulation of follicle-stimulating hormone secretion / negative regulation of chondrocyte proliferation / Antagonism of Activin by Follistatin / regulation of lung blood pressure / lymphatic endothelial cell differentiation / response to insecticide / pulmonary valve development / Glycoprotein hormones / chondrocyte development / tricuspid valve morphogenesis / negative regulation of cell proliferation involved in heart valve morphogenesis / aortic valve development / positive regulation of follicle-stimulating hormone secretion / BMP binding / negative regulation of muscle cell differentiation / venous blood vessel development / atrial septum morphogenesis / endocardial cushion development / maternal placenta development / proteoglycan biosynthetic process / endochondral bone morphogenesis / positive regulation of cartilage development / transforming growth factor beta receptor activity / pituitary gland development / lung vasculature development / lymphangiogenesis / mitral valve morphogenesis / retina vasculature development in camera-type eye / positive regulation of axon extension involved in axon guidance / artery development / cellular response to cholesterol / transforming growth factor beta receptor activity, type I / activin receptor activity, type I / activin receptor activity, type II / BMP receptor activity / receptor protein serine/threonine kinase / transforming growth factor beta receptor activity, type II / transforming growth factor beta receptor activity, type III / cellular response to BMP stimulus / Signaling by BMP / Signaling by Activin / activin receptor signaling pathway / cellular response to leptin stimulus / endothelial cell apoptotic process / oocyte development / positive regulation of ossification / negative regulation of systemic arterial blood pressure / cellular response to thyroid hormone stimulus / endothelial cell proliferation / limb development / anterior/posterior pattern specification / cell surface receptor protein serine/threonine kinase signaling pathway / negative regulation of vasoconstriction / ventricular septum morphogenesis / lung alveolus development / seminiferous tubule development / growth factor binding / blood vessel development / fat cell differentiation / outflow tract morphogenesis / cellular response to Thyroglobulin triiodothyronine / mesoderm formation / cellular response to interleukin-1 / positive regulation of epithelial cell migration / positive regulation of SMAD protein signal transduction / blood vessel remodeling / BMP signaling pathway / positive regulation of bone mineralization / positive regulation of osteoblast differentiation / negative regulation of insulin secretion / ovarian follicle development / clathrin-coated pit / cellular response to cAMP / cellular response to calcium ion / protein tyrosine kinase binding / cellular response to starvation / basal plasma membrane / positive regulation of apoptotic signaling pathway / cytokine activity / cell periphery / adherens junction / stem cell differentiation / apoptotic signaling pathway / growth factor activity / negative regulation of smooth muscle cell proliferation / defense response / negative regulation of cell growth / cellular response to growth factor stimulus / hormone activity / caveola / response to wounding / cellular response to insulin stimulus / osteoblast differentiation / regulation of cell population proliferation / spermatogenesis / cell differentiation
Similarity search - Function
Inhibin, beta B subunit / TGF-beta, propeptide / TGF-beta propeptide / Activin types I and II receptor domain / Activin types I and II receptor domain / Transforming growth factor beta, conserved site / TGF-beta family signature. / Transforming growth factor-beta-related / Transforming growth factor-beta (TGF-beta) family / Transforming growth factor-beta, C-terminal ...Inhibin, beta B subunit / TGF-beta, propeptide / TGF-beta propeptide / Activin types I and II receptor domain / Activin types I and II receptor domain / Transforming growth factor beta, conserved site / TGF-beta family signature. / Transforming growth factor-beta-related / Transforming growth factor-beta (TGF-beta) family / Transforming growth factor-beta, C-terminal / Transforming growth factor beta like domain / TGF-beta family profile. / Ser/Thr protein kinase, TGFB receptor / Cystine-knot cytokine / Snake toxin-like superfamily / Protein kinase domain / Protein kinase, ATP binding site / Protein kinases ATP-binding region signature. / Protein kinase domain profile. / Protein kinase domain / Protein kinase-like domain superfamily
Similarity search - Domain/homology
Inhibin beta B chain / Bone morphogenetic protein receptor type-2
Similarity search - Component
Biological speciesHomo sapiens (human)
MethodX-RAY DIFFRACTION / SYNCHROTRON / MOLECULAR REPLACEMENT / Resolution: 3.45 Å
AuthorsChu, K.Y. / Malik, A. / Thamilselvan, V. / Martinez-Hackert, E.
Funding support United States, 1items
OrganizationGrant numberCountry
National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS)R01GM121499 United States
CitationJournal: J.Biol.Chem. / Year: 2022
Title: Type II BMP and activin receptors BMPR2 and ACVR2A share a conserved mode of growth factor recognition.
Authors: Chu, K.Y. / Malik, A. / Thamilselvan, V. / Martinez-Hackert, E.
History
DepositionMar 2, 2022Deposition site: RCSB / Processing site: RCSB
Revision 1.0Jun 22, 2022Provider: repository / Type: Initial release
Revision 1.1Jul 6, 2022Group: Database references / Category: citation / Item: _citation.journal_volume / _citation.title
Revision 1.2Oct 18, 2023Group: Data collection / Refinement description
Category: chem_comp_atom / chem_comp_bond ...chem_comp_atom / chem_comp_bond / pdbx_initial_refinement_model / struct_ncs_dom_lim
Item: _struct_ncs_dom_lim.beg_auth_comp_id / _struct_ncs_dom_lim.beg_label_asym_id ..._struct_ncs_dom_lim.beg_auth_comp_id / _struct_ncs_dom_lim.beg_label_asym_id / _struct_ncs_dom_lim.beg_label_comp_id / _struct_ncs_dom_lim.beg_label_seq_id / _struct_ncs_dom_lim.end_auth_comp_id / _struct_ncs_dom_lim.end_label_asym_id / _struct_ncs_dom_lim.end_label_comp_id / _struct_ncs_dom_lim.end_label_seq_id
Revision 1.3Nov 20, 2024Group: Structure summary / Category: pdbx_entry_details / pdbx_modification_feature

-
Structure visualization

Structure viewerMolecule:
MolmilJmol/JSmol

Downloads & links

-
Assembly

Deposited unit
A: Inhibin beta B chain
B: Inhibin beta B chain
C: Inhibin beta B chain
E: Bone morphogenetic protein receptor type-2
F: Bone morphogenetic protein receptor type-2
G: Bone morphogenetic protein receptor type-2


Theoretical massNumber of molelcules
Total (without water)75,7606
Polymers75,7606
Non-polymers00
Water00
1
A: Inhibin beta B chain
E: Bone morphogenetic protein receptor type-2


Theoretical massNumber of molelcules
Total (without water)25,2532
Polymers25,2532
Non-polymers00
Water0
TypeNameSymmetry operationNumber
identity operation1_555x,y,z1
2
B: Inhibin beta B chain
F: Bone morphogenetic protein receptor type-2


Theoretical massNumber of molelcules
Total (without water)25,2532
Polymers25,2532
Non-polymers00
Water0
TypeNameSymmetry operationNumber
identity operation1_555x,y,z1
3
C: Inhibin beta B chain
G: Bone morphogenetic protein receptor type-2


Theoretical massNumber of molelcules
Total (without water)25,2532
Polymers25,2532
Non-polymers00
Water0
TypeNameSymmetry operationNumber
identity operation1_555x,y,z1
Unit cell
Length a, b, c (Å)80.960, 115.460, 110.160
Angle α, β, γ (deg.)90.000, 100.920, 90.000
Int Tables number5
Space group name H-MC121
Noncrystallographic symmetry (NCS)NCS domain:
IDEns-IDDetails
11(chain A and (resid 293 through 298 or (resid 299...
21(chain B and (resid 293 through 300 or (resid 301...
31(chain C and (resid 293 through 298 or (resid 299...
12(chain E and (resid 32 through 39 or (resid 40...
22(chain F and ((resid 32 through 33 and (name N...

NCS domain segments:
Dom-IDComponent-IDEns-IDBeg auth comp-IDBeg label comp-IDEnd auth comp-IDEnd label comp-IDSelection detailsAuth asym-IDLabel asym-IDAuth seq-IDLabel seq-ID
111GLYGLYGLYGLY(chain A and (resid 293 through 298 or (resid 299...AA293 - 2981 - 6
121ARGARGARGARG(chain A and (resid 293 through 298 or (resid 299...AA2997
131GLYGLYALAALA(chain A and (resid 293 through 298 or (resid 299...AA293 - 4071 - 115
141GLYGLYALAALA(chain A and (resid 293 through 298 or (resid 299...AA293 - 4071 - 115
151GLYGLYALAALA(chain A and (resid 293 through 298 or (resid 299...AA293 - 4071 - 115
161GLYGLYALAALA(chain A and (resid 293 through 298 or (resid 299...AA293 - 4071 - 115
211GLYGLYTHRTHR(chain B and (resid 293 through 300 or (resid 301...BB293 - 3001 - 8
221ASNASNASNASN(chain B and (resid 293 through 300 or (resid 301...BB3019
231GLYGLYALAALA(chain B and (resid 293 through 300 or (resid 301...BB293 - 4071 - 115
241GLYGLYALAALA(chain B and (resid 293 through 300 or (resid 301...BB293 - 4071 - 115
251GLYGLYALAALA(chain B and (resid 293 through 300 or (resid 301...BB293 - 4071 - 115
261GLYGLYALAALA(chain B and (resid 293 through 300 or (resid 301...BB293 - 4071 - 115
311GLYGLYGLYGLY(chain C and (resid 293 through 298 or (resid 299...CC293 - 2981 - 6
321ARGARGARGARG(chain C and (resid 293 through 298 or (resid 299...CC2997
112ARGARGPROPRO(chain E and (resid 32 through 39 or (resid 40...ED32 - 396 - 13
122TYRTYRGLUGLU(chain E and (resid 32 through 39 or (resid 40...ED40 - 5414 - 28
132GLUGLUPROPRO(chain E and (resid 32 through 39 or (resid 40...ED31 - 1335 - 107
142GLUGLUPROPRO(chain E and (resid 32 through 39 or (resid 40...ED31 - 1335 - 107
152GLUGLUPROPRO(chain E and (resid 32 through 39 or (resid 40...ED31 - 1335 - 107
162GLUGLUPROPRO(chain E and (resid 32 through 39 or (resid 40...ED31 - 1335 - 107
212ARGARGLEULEU(chain F and ((resid 32 through 33 and (name N...FE32 - 336 - 7
222ARGARGPROPRO(chain F and ((resid 32 through 33 and (name N...FE32 - 1336 - 107
232ARGARGPROPRO(chain F and ((resid 32 through 33 and (name N...FE32 - 1336 - 107

NCS ensembles :
ID
1
2

-
Components

#1: Protein Inhibin beta B chain / Activin beta-B chain


Mass: 12825.582 Da / Num. of mol.: 3
Source method: isolated from a genetically manipulated source
Source: (gene. exp.) Homo sapiens (human) / Gene: INHBB / Production host: Cricetulus griseus (Chinese hamster) / References: UniProt: P09529
#2: Protein Bone morphogenetic protein receptor type-2 / BMP type-2 receptor / BMPR-2 / Bone morphogenetic protein receptor type II / BMP type II receptor / BMPR-II


Mass: 12427.736 Da / Num. of mol.: 3
Source method: isolated from a genetically manipulated source
Source: (gene. exp.) Homo sapiens (human) / Gene: BMPR2, PPH1 / Production host: Cricetulus griseus (Chinese hamster)
References: UniProt: Q13873, receptor protein serine/threonine kinase
Has protein modificationY

-
Experimental details

-
Experiment

ExperimentMethod: X-RAY DIFFRACTION / Number of used crystals: 1

-
Sample preparation

CrystalDensity Matthews: 3.34 Å3/Da / Density % sol: 58.81 %
Crystal growTemperature: 294 K / Method: vapor diffusion, hanging drop / pH: 5.4
Details: 175 mM Ammonium Sulfate 100 mM Bis Tris 14% PEG 3000

-
Data collection

DiffractionMean temperature: 100 K / Serial crystal experiment: N
Diffraction sourceSource: SYNCHROTRON / Site: APS / Beamline: 21-ID-G / Wavelength: 0.97857 Å
DetectorType: MARMOSAIC 300 mm CCD / Detector: CCD / Date: Feb 22, 2017
RadiationProtocol: SINGLE WAVELENGTH / Monochromatic (M) / Laue (L): M / Scattering type: x-ray
Radiation wavelengthWavelength: 0.97857 Å / Relative weight: 1
ReflectionResolution: 3.45→60.34 Å / Num. obs: 13152 / % possible obs: 99.8 % / Redundancy: 3.7 % / Biso Wilson estimate: 112.69 Å2 / CC1/2: 0.988 / Rmerge(I) obs: 0.102 / Rpim(I) all: 0.062 / Rrim(I) all: 0.12 / Χ2: 0.57 / Net I/σ(I): 3
Reflection shellResolution: 3.45→3.78 Å / Num. unique obs: 3121 / CC1/2: 0.909 / % possible all: 100

-
Processing

Software
NameVersionClassification
PHENIX1.17.1_3660refinement
PDB_EXTRACT3.27data extraction
HKL-2000data reduction
SCALEPACKdata scaling
MOLREPphasing
RefinementMethod to determine structure: MOLECULAR REPLACEMENT
Starting model: 2HLR

2hlr


Resolution: 3.45→36.06 Å / SU ML: 0.45 / Cross valid method: THROUGHOUT / σ(F): 1.35 / Phase error: 33.27 / Stereochemistry target values: ML
RfactorNum. reflection% reflection
Rfree0.2844 646 4.93 %
Rwork0.2357 12469 -
obs0.2381 13115 99.57 %
Solvent computationShrinkage radii: 0.9 Å / VDW probe radii: 1.11 Å / Solvent model: FLAT BULK SOLVENT MODEL
Displacement parametersBiso max: 326.84 Å2 / Biso mean: 141.7258 Å2 / Biso min: 53.54 Å2
Refinement stepCycle: final / Resolution: 3.45→36.06 Å
ProteinNucleic acidLigandSolventTotal
Num. atoms4358 0 0 0 4358
Num. residues----587
Refine LS restraints NCS
Ens-IDDom-IDAuth asym-IDNumberRefine-IDRmsType
11A975X-RAY DIFFRACTION10.949TORSIONAL
12B975X-RAY DIFFRACTION10.949TORSIONAL
13C975X-RAY DIFFRACTION10.949TORSIONAL
21E414X-RAY DIFFRACTION10.949TORSIONAL
22F414X-RAY DIFFRACTION10.949TORSIONAL
LS refinement shell

Refine-ID: X-RAY DIFFRACTION / Rfactor Rfree error: 0 / Total num. of bins used: 5

Resolution (Å)Rfactor RfreeNum. reflection RfreeRfactor RworkNum. reflection RworkNum. reflection all% reflection obs (%)
3.45-3.720.29411320.263224882620100
3.72-4.090.32111240.22524922616100
4.09-4.680.26841250.197624972622100
4.68-5.890.26141330.232725092642100
5.89-36.060.29311320.25462483261598
Refinement TLS params.Method: refined / Origin x: 1.4519 Å / Origin y: -32.9811 Å / Origin z: 36.0131 Å
111213212223313233
T0.8649 Å2-0.0828 Å20.1325 Å2-0.7163 Å20.0568 Å2--0.7755 Å2
L1.3553 °2-0.0664 °2-0.6714 °2-1.6416 °20.4342 °2--1.3907 °2
S-0.1986 Å °0.2911 Å °-0.0021 Å °-0.5955 Å °0.0989 Å °-0.4153 Å °-0.0125 Å °0.1515 Å °0.1242 Å °
Refinement TLS group
IDRefine-IDRefine TLS-IDSelection detailsAuth asym-IDAuth seq-ID
1X-RAY DIFFRACTION1allA293 - 407
2X-RAY DIFFRACTION1allB293 - 407
3X-RAY DIFFRACTION1allC293 - 407
4X-RAY DIFFRACTION1allE31 - 133
5X-RAY DIFFRACTION1allF32 - 133
6X-RAY DIFFRACTION1allG30 - 131

+
About Yorodumi

-
News

-
Feb 9, 2022. New format data for meta-information of EMDB entries

New format data for meta-information of EMDB entries

  • Version 3 of the EMDB header file is now the official format.
  • The previous official version 1.9 will be removed from the archive.

Related info.:EMDB header

External links:wwPDB to switch to version 3 of the EMDB data model

-
Aug 12, 2020. Covid-19 info

Covid-19 info

URL: https://pdbj.org/emnavi/covid19.php

New page: Covid-19 featured information page in EM Navigator.

Related info.:Covid-19 info / Mar 5, 2020. Novel coronavirus structure data

+
Mar 5, 2020. Novel coronavirus structure data

Novel coronavirus structure data

Related info.:Yorodumi Speices / Aug 12, 2020. Covid-19 info

External links:COVID-19 featured content - PDBj / Molecule of the Month (242)：Coronavirus Proteases

+
Jan 31, 2019. EMDB accession codes are about to change! (news from PDBe EMDB page)

EMDB accession codes are about to change! (news from PDBe EMDB page)

  • The allocation of 4 digits for EMDB accession codes will soon come to an end. Whilst these codes will remain in use, new EMDB accession codes will include an additional digit and will expand incrementally as the available range of codes is exhausted. The current 4-digit format prefixed with “EMD-” (i.e. EMD-XXXX) will advance to a 5-digit format (i.e. EMD-XXXXX), and so on. It is currently estimated that the 4-digit codes will be depleted around Spring 2019, at which point the 5-digit format will come into force.
  • The EM Navigator/Yorodumi systems omit the EMD- prefix.

Related info.:Q: What is EMD? / ID/Accession-code notation in Yorodumi/EM Navigator

External links:EMDB Accession Codes are Changing Soon! / Contact to PDBj

+
Jul 12, 2017. Major update of PDB

Major update of PDB

  • wwPDB released updated PDB data conforming to the new PDBx/mmCIF dictionary.
  • This is a major update changing the version number from 4 to 5, and with Remediation, in which all the entries are updated.
  • In this update, many items about electron microscopy experimental information are reorganized (e.g. em_software).
  • Now, EM Navigator and Yorodumi are based on the updated data.

External links:wwPDB Remediation / Enriched Model Files Conforming to OneDep Data Standards Now Available in the PDB FTP Archive

-
Yorodumi

Thousand views of thousand structures

  • Yorodumi is a browser for structure data from EMDB, PDB, SASBDB, etc.
  • This page is also the successor to EM Navigator detail page, and also detail information page/front-end page for Omokage search.
  • The word "yorodu" (or yorozu) is an old Japanese word meaning "ten thousand". "mi" (miru) is to see.

Related info.:EMDB / PDB / SASBDB / Comparison of 3 databanks / Yorodumi Search / Aug 31, 2016. New EM Navigator & Yorodumi / Yorodumi Papers / Jmol/JSmol / Function and homology information / Changes in new EM Navigator and Yorodumi

Read more